Transforming Healthcare: AI in Diagnostics Market to See 27.6% CAGR Growth
"AI in clinical and molecular diagnostics uses artificial intelligence to analyze medical data, such as lab tests and genetic information, more quickly and accurately. BCC Research Highlights Explosive Growth in AI-Driven Clinical and Molecular Diagnostics, Projecting Market Expansion from $2.6 Billion in 2024 to $8.9 Billion by 2029
BOSTON, Jan. 9, 2025 /PRNewswire/ -- According to the latest study from BCC Research AI in Clinical and Molecular Diagnostics Market is expected to grow from $2.6 billion in 2024 and is projected to reach $8.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.6% during the forecast period of 2024 to 2029.
This report provides an overview of the global market for AI in clinical and molecular diagnostics, covering market size, growth trends, and key applications such as medical imaging, genomics, and lab testing. It focuses on the factors driving AI adoption, challenges, and opportunities, along with profiles of leading companies and regional insights. Emerging trends in personalized medicine and telehealth are also discussed, making this report a valuable resource for healthcare providers, tech developers, and policymakers.
Interesting and surprising facts:
Two Powerful Ways AI is Revolutionizing Healthcare Diagnostics
AI can analyze your genetic data to identify potential health risks, even before you show any symptoms. This means doctors can take preventive measures to keep you healthy.
AI's language processing abilities allow it to read and understand doctor's notes, extracting valuable information that might have been overlooked. This helps doctors make more accurate diagnoses, develop personalized treatment plans and improve patient care.
Factors contributing to the growth include:
Sample Copy of the AI in Clinical and Molecular Diagnostics Market Report
Report Synopsis
Report Metric | Details |
Base year considered | 2023 |
Forecast period considered | 2024-2029 |
Base year market size | $2.3 billion |
Market size forecast | $8.9 billion |
Growth rate | CAGR of 27.6% for the forecast period of 2024-2029 |
Segments covered | Type, Component, and Region |
Regions covered | North America, Europe, Asia-Pacific, and Rest of the World |
Countries covered | U.S., Canada, Mexico, Germany, France, U.K., Italy, Russia, Spain, China, India, Japan, Australia, Singapore, South Korea |
Market drivers | • Investment in the AI health sector • Increasing prevalence of chronic and infectious diseases • Introduction of software with AI • Opportunities in developing markets |
This report addresses the following key questions:
The market is projected to grow from $2.6 billion in 2024 to $8.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.6% during the forecast period.
The AI in clinical and molecular diagnostics market is segmented based on type, component, and region.
By type, molecular diagnostics is expected to contribute the highest share of the market by the end of 2029.
Software is the fastest growing component.
Leading companies in the market include:
- Atomwise Inc.
- F. Hoffmann-La Roche Ltd.
- Fujifilm Holdings Corp.
- GE Healthcare
- Illumina Inc.
- Koninklijke Philips N.V.
- Medtronic
- Microsoft Corp.
- Siemens Healthineers AG
- Thermo Fisher Scientific Inc.
- Butterfly Network Inc.
- Enlitic
- Intel Corp.
- Merative
- Nvidia Corp.
- Qure.Ai
- Synapsica Healthcare Pvt Ltd.
Directly purchase a copy of the report from BCC Research.
For further information on these reports or to purchase one, please contact info@bccresearch.com.
About BCC Research
BCC Research market research reports provide objective, unbiased measurement and assessment of market opportunities. Our experienced industry analysts' goal is to help readers make informed business decisions, free of noise and hype.
Contact Us
Corporate HQ: 50 Milk St. Ste 16, Boston, MA 02109, USA
Email: info@bccresearch.com,
Phone: +1 781-489-7301
For media inquiries, email press@bccresearch.com or visit our media page for access to our market research library.
Any data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher.
Logo: https://mma.prnewswire.com/media/2183242/BCC_Research_Logo.jpg
View original content to download multimedia:https://www.prnewswire.com/news-releases/transforming-healthcare-ai-in-diagnostics-market-to-see-27-6-cagr-growth-302347335.html
SOURCE BCC Research LLC